32 results
8-K
EX-1.1
ANNX
Annexon Inc
7 Jun 24
Annexon Announces Pricing of $125 Million Underwritten Public Offering
4:42pm
contract, commitment, agreement, understanding or arrangement of any kind relating to the issuance of any capital stock of the Company or any
8-K
EX-99.2
ANNX
Annexon Inc
4 Jun 24
Annexon Announces Positive Topline Results from Pivotal Phase 3 Trial for First-in-Class C1q Blocking Antibody ANX005 in Guillain-Barré Syndrome
7:05am
for your WARRIOR SPIRIT AND ALL FOR ONE COMMITMENT! 28
Thank You! Q&A Annexon Biosciences sincerely thanks all the patients, families, and study
8-K
EX-99.1
v3i7h84cjkufh0ay 8y
4 Mar 24
Regulation FD Disclosure
5:25pm
8-K
EX-1.1
usonq 3yht0
21 Dec 23
Annexon Announces Pricing of $125.0 Million Underwritten Public Offering of Common Stock
4:09pm
8-K
EX-10.1
3yibipla1 hyqe5j
8 Jul 22
Annexon Announces $130 Million Private Placement Financing
5:19pm
8-K
EX-99.1
qeqx1
4 Oct 21
Departure of Directors or Certain Officers
4:06pm
10-K
25zrcebd2esv
25 Mar 21
Annual report
7:16am
10-Q
8o1ap5m3
8 Sep 20
Quarterly report
5:18pm
424B4
4js7omo
24 Jul 20
Prospectus supplement with pricing info
5:15pm
S-1/A
EX-1.1
xumod0rluzx72dot
20 Jul 20
IPO registration (amended)
6:07am
S-1/A
uot6a2f
20 Jul 20
IPO registration (amended)
6:07am